Anti-ORF52 [ORF52] Product
Kaposi’s sarcoma-associated herpesvirus (KSHV) has been identified as the causative agent of Kaposi’s sarcoma, the most common malignancy in HIV-infected individuals.
Kaposi’s sarcoma-associated herpesvirus (KSHV) has been identified as the causative agent of Kaposi’s sarcoma, the most common malignancy in HIV-infected individuals.
Kaposi’s sarcoma- associated herpesvirus (KSHV) has been identified as the causative agent of Kaposi’s sarcoma, the most common malignancy in HIV-infected individuals. KSHV has also been shown to be be […]
Originally raised against the human mammary carcinoma cell line (ZR-75-1), reacts with a carcinoma-associated antigen in both adenocarcinomas and squamous cell carcinomas of different origins.
Immortalised ER-Hoxb8 bone marrow progenitor cells expressing cell surface antigens TY-1.1 used to study macrophage functions with implications in cancer immunotherapies targeting the motility of tumour–associated macrophages
[…] and transmits an inhibitory signal to T cells. Mutations in the CTLA4 gene have been associated with various autoimmune diseases, such as systemic lupus erythematosus, insulin-dependent diabetes mellitus, and other […]
Immortalised ER-Hoxb8 bone marrow progenitor cells expressing cell surface antigens TY-1.1 used to study macrophage functions with implications in cancer immunotherapies targeting the motility of tumour–associated macrophages
HLA-DR-associated invariant chain (CD74) plays a role in antigen presentation.
Originally raised against the human mammary carcinoma cell line (ZR-75-1), reacts with a carcinoma-associated antigen in both adenocarcinomas and squamous cell carcinomas of different origins.
The half life of CD74 on the cell surface is relatively short lasting only 3 to 4 min, before internalization. It has been suggested that CD74 on the cell surface binds MHC class II molecules which have lost their antigenic peptide promoting internalization and reloading with antigenic peptide.
Recombinant version of CRT trademarked famous anti-CD3 monoclonal antibody, capable of differentiating between T vs B cells lymphomas and leukaemias. Background and Research Application The CD3 complex, composed of four…
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.